Strategy Inc: Form 10-Q for the period ended Mar 31, 2022
Filed with the SEC on May 3, 2022 and accepted by EDGAR at May 3, 2022, 16:09 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-01-01 to 2022-03-31 | $119.3m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2022-01-01 to 2022-03-31 | $25.7m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2022-01-01 to 2022-03-31 | $93.6m | us-gaap:GrossProfit |
| Research and development | 3 months2022-01-01 to 2022-03-31 | $33.5m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2022-01-01 to 2022-03-31 | −$170.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2022-01-01 to 2022-03-31 | −$48.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-01-01 to 2022-03-31 | −$130.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2022-01-01 to 2022-03-31 | −$11.58 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-01-01 to 2022-03-31 | −$11.58 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-01-01 to 2022-03-31 | 11,289,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2022-01-01 to 2022-03-31 | $43.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2022-01-01 to 2022-03-31 | $641.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2022-03-31 | $92.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-03-31 | $247.0m | us-gaap:AssetsCurrent |
| Total assets | At period end2022-03-31 | $3.64bn | us-gaap:Assets |
| Current liabilities | At period end2022-03-31 | $304.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-03-31 | $2.78bn | us-gaap:Liabilities |
| Long-term debt | At period end2022-03-31 | $2.36bn | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2022-03-31 | $863.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001564590-22-017437. Last ingested by Listed: Nov 11, 2026, 00:19 ET. Listed shows no prices and gives no investment advice.